Drug Database
Back to search

Poland· PL-100044307

Mivacron

A mivacurium chloride product containing mivacurii chloridum, registered in Poland by Aspen Pharma Trading Ltd.. The same ATC class is registered in 8 of our 19 countries.

ATC M03AC10

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedMivacronATCM03AC10REGISTER NO.PL-100044307PACKS LISTED4CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about mivacurii chloridumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Mivacurium chloride is registered in 8 of 19 countries.

Countries holding a registration under ATC M03AC10 (mivacurium chloride), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 6 of them publish a price we can compare per daily dose
Search mivacurium chloride products by name

Mivacurium chloride · ATC M03AC10

8 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Finlandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Mivacurii chloridum
Manufacturer
Aspen Pharma Trading Ltd.
Country
Poland (PL)
ATC code
M03AC10
ATC class
Mivacurium chloride
Defined daily dose
14 mg, P
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 4

  • gtin
    05909990372515
  • gtin
    03400956511624
  • gtin
    05060598252033
  • gtin
    05909990372522

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

76 interactions on record for mivacurium chloride.

Graded by severity as the source publishes them — 12 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check mivacurium chloride against other medicinesHow interaction checks work

Mivacurium chloride · interactions on record

76 records

  • 12 severe
  • 60 moderate
  • 4 minor

Most severe, free to view

  • NeomycinA07AA01severe
  • StreptomycinA07AA04severe
  • Polymyxin BA07AA05severe
  • ParomomycinA07AA06severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Mivacurium chloride in 6 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All mivacurium chloride products

Authorised across Europe · EMA

The same active substance is authorised in 5 EEA countries. Names it is sold under:

  • Austria · Mivacron
  • Germany · Mivacurium Kalceks
  • Latvia · Mivacurium Kalceks
  • Malta · Mivacron
  • Netherlands · Mivacron

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/1f46837f-49aa-4e2d-8ae4-f6bd32f3470d
GET /v1/drugs/1f46837f-49aa-4e2d-8ae4-f6bd32f3470d?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Roztwór do wstrzykiwań",
  "source": "urpl",
  "strength": "2 mg/ml",
  "packaging": "05909990372515 ¦ Lz ¦ 6611\n5 amp. 5 ml\n¦ UR/Z/4c/001/22 - 03400956511624 ¦ UR/Z/4c/022/21 - 03400956511624 ¦ UR/Z/4c/099/23 - 03400956511624 ¦ UR/Z/4c/055/25 - 05060598252033\n05909990372522 ¦ Lz ¦ 16509\n5 amp. 10 ml",
  "substance": "Mivacurii chloridum 2,140 mg/ml (produkt zawiera 5% nadmiaru substancji czynnej)",
  "common_name": "Mivacurii chloridum",
  "pl_product_id": "100044307",
  "pozwolenie_nr": "03725",
  "auth_procedure": "NAR",
  "authorisation_validity": "Bezterminowe"
}
API referenceMCP serverPlans

See everything about mivacurium chloride.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console